Position in SNY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$20,019,697
-$9,977,796 QoQ
Shares Held
469,285
-24.6% QoQ
Ownership
0.020%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#57
of 712 holders
Holding Since
Mar 2021
9 quarters on record
Voting authority
Sole 95%
Shared 0%
None 5%
Common Shares in SNY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026BROWN ADVISORY INC holds $966,440,001 across 15 Drug Manufacturers - General names. SNY ranks #8 (2.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
1,028,187 | $261,128,650 | |
| 2 | ABBV |
AbbVie Inc.
|
870,702 | $219,103,450 | |
| 3 | MRK |
Merck & Co., Inc.
|
1,365,877 | $175,515,193 | |
| 4 | LLY |
ELI LILLY & Co
|
121,140 | $145,298,959 | |
| 5 | AMGN |
Amgen Inc
|
118,830 | $43,030,717 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
252,085 | $31,848,418 | |
| 7 | NVS |
Novartis AG
|
186,086 | $29,163,396 | |
| 8 | SNY |
Sanofi
This page
|
469,285 | $20,019,697 |
All Filings in SNY
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $20,019,697 | 469,285 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $29,997,493 | 622,613 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $26,222,722 | 541,121 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $24,082,241 | 510,217 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $20,384,886 | 421,960 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $17,449,711 | 314,636 | Shares | Defined | 2025-04-30 | |
| 2024-12-31 | $11,577,755 | 240,053 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $7,596,439 | 131,814 | Shares | Defined | 2024-11-13 | |
| 2021-03-31 | $231,274 | 4,676 | Shares | Defined | 2021-05-14 | |
| No filing history on record for this holder in this stock. | ||||||